Taylor and Patrick co-authored a commentary on recent progress in engineering cell therapies for cancer, including perspectives on exciting recent innovations in this space. Read more here.
Abbvie senior scientist Mikkel Algire highlights technologies for engineering cell-based therapies for cancer. Read more here.
This collaboration with the Nguyen and Schatz labs decribes the development of highly stable and stimuli/pH-responsive ultra-small polymer-grafted nanobins (usPGNs) as candidate nano-scale drug delivery vehicles. Read more here.
This chapter was published as part of an issue of Methods in Molecular Biology dedicated to the study and therapeutic use of Extracellular RNA. Read more here.
This study, published in Protein Engineering, Design, and Selection, reports the BERDI method for engineering novel metabolite-responsive biosensors, for applications ranging from metabolic engineering to fundamental research. Read more here.
Joseph’s research is highlighted in an article featuring undergraduate summer research. Read more here.
This review discusses both recent advances and emerging general principles for using mammalian synthetic biology to build cell-based therapies that are safe and effective. Read more here.
This chapter summarizes key strategies and challenges associated with studying and harnessing EV-mediated transfer for therapeutic applications, while providing contemporary perspectives on how choices of systems design and analysis method may impact the efficacy of EV-based therapies and the interpretation of EV-based investigations. Read more here.
Kelly’s thesis research was profiled in a feature in Northwestern’s Alumni Magazine
Josh was selected to join the Scientific Executive Committee of GP-Write, a multinational synthetic biology project dedicated to realizing whole genome synthesis in order to understand, engineer and test living systems.